MICHAEL SARIBALAS: Open Payments
NPI 1164454211 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$170,481 in 184 payments from 6 companies in 2025. Trend: 2023 $273,286 · 2024 $149,395 · 2025 $170,481
Speaker / faculty: $128,302Travel & lodging: $17,992Honoraria: $16,538Consulting: $3,990Food & beverage: $3,660
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 127 | $113,664 |
| Axsome Therapeutics, Inc. | 9 | $17,265 |
| ABBVIE INC. | 16 | $15,815 |
| Vanda Pharmaceuticals Inc. | 23 | $15,404 |
| Alkermes, Inc. | 8 | $8,182 |
| Noctrix Health, Inc. | 1 | $151 |
Products named: COBENFY, Auvelity, VRAYLAR, FANAPT, LYBALVI, NIDRA.
Industry payments across OH — which companies pay providers there.
